Lixte Biotechnology Holdings effects 1-for-10 reverse stock split

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Reverse stock split effective June 2, 2023; every 10 shares combined into 1.
Stockholders approved the split at a Special Meeting on May 26, 2023.
Common stock begins trading on Nasdaq on a split-adjusted basis June 5, 2023.
No fractional shares issued; any fractional share rounded up to nearest whole share.
Proportionate adjustments made to options, warrants, and Series A Preferred conversion.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LIXTE BIOTECHNOLOGY HOLDINGS, INC.: Filed a Certificate of Amendment to the Certificate of Incorporation to effect a 1-for-10 reverse stock split of common stock, effective June 2, 2023 (effective 2023-06-02).

Change: charter amendment
Effective: 2023-06-02

Exact text from the filing

On June 1, 2023, Lixte Biotechnology Holdings, Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of its outstanding shares of common stock. The Amendment was effective on June 2, 2023 (the “Effective Time”).

View on SEC.gov

Browse all governance changes →

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-020163

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.